[ad_1]
Bill gates Talk about COVID-19 and America. But not only. “It is unfortunate that many statements by President Trump have caused the Covid vaccine to be perceived as a political issue,” Gates told La Stampa, rejecting the American response to the disastrous pandemic and warning that the fall threatens to bring us back to the drama. of spring, if no interventions are necessary. However, he is optimistic about vaccines, predicting that at least three will be authorized by the end of the year, although it will take until 2022 to see the true end of the virus. “Unfortunately, this year we are talking about the setbacks caused by the pandemic. The impact on health is a 25-year setback and extreme poverty has grown by 7%. We have to stop the virus, but a global collaboration is needed. Working together to create the vaccine, test it, produce it, distribute it. Access will make a difference. According to studies by Northeastern University, if the first two billion doses go only to rich countries, we will have twice as many deaths, “says Gates, who says”pessimistic about what autumn will be like in the northern hemisphere. If we don’t intervene, the death toll, even in the United States, will return to spring levels.
Coronavirus, WHO: deaths in Europe will increase in October and November
Covid, WHO: “No to the salute with the elbow, it favors contagion”
“The good news – he adds – is that we have several promising vaccines, and they could receive authorization for emergency use from the FDA or the MHRA at the end of the year, or indeed early next year. I hope two or three have it. Some think before November (date of the presidential elections of the United States), but it is not probable. Pfizer is the only one that could do this, but many more are expected to have test data early next year. The first vaccine may not be the definitive one, we will have to work more in the secondary ones.
Coronavirus, Pfizer vaccine: in October we will know if it works
“The Gates Foundation – says Bill Gates in the interview – is focused on those that can be produced on a large scale, with a low cost, between 2 and 3 dollars per dose. This includes AstraZeneca Oxford, Novavax, Johnson & Johnson, and Sanofi. Let’s try to see if they work and create a global production capacity of more than 1.5 billion doses a year. “. «We work with producers in developing countries, such as the Serum Institute in India. If they are effective, even with a vaccination level of 60%, we will stop the exponential spread of the disease. Next year we will reduce the death toll and in 2022 the pandemic will end» Points out.
Last updated: 16:07
© REPRODUCTION RESERVED
[ad_2]
